Glaxosmithkline Vaccines SRL

Glaxosmithkline Vaccines SRL is a company in Siena, Italy that has taken part in 30 EU-funded projects since 2008, receiving €10.8M in EU funding and leading 14 as coordinator.

EU funding received€10.8M
EU projects30
As coordinator14
Running now0
First EU project2008
Latest project2020
CountryItaly
EU registration (PIC)999988618
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Glaxosmithkline Vaccines SRL's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€7.3M · 21 projects
  • Horizon 2020€3.6M · 9 projects

Projects

30 EU-funded projects, newest first. Glaxosmithkline Vaccines SRL led 14 of them as coordinator. Each links to the official record.

  • PAVaxPartner

    A training network for the design of new synthetic carbohydrate-based vaccines to combat antibiotic resistant Pseudomonas aeruginosa

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €523ktheir share
  • NEWCARBOVAXPartner

    New generation of carbohydrate-based vaccines via rational understanding of their immunological mechanism

    Horizon 2020 · 2017–2019 · Project on CORDIS ↗

  • DISSectionCoordinator

    Doctoral Industrial School on Human Skin models for Staphylococcal infections

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €516ktheir share
  • VADEMACoordinator

    Doctoral Industrial School for Vaccine Design through Structural Mass Spectrometry

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €516ktheir share
  • PHA-ST-TRAIN-VACPartner

    Leveraging Pharmaceutical Sciences and Structural Biology Training to develop 21st Century Vaccines

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €516ktheir share
  • GLYCOVAXCoordinator

    A training network for the rational design of the next generation of well-defined glycoconjugate vaccines

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €516ktheir share
  • SVNanoVaxCoordinator

    Structural Vaccinology in the design of bionanoparticles with multi-copy antigen display for vaccines with enhanced efficacy

    Horizon 2020 · 2015–2017 · Project on CORDIS ↗

    €168ktheir share
  • FLUCOPPartner

    Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection

    FP7 (2007 to 2013) · 2015–2020 · Project on CORDIS ↗

  • DiViNePartner

    Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes

    Horizon 2020 · 2015–2020 · Project on CORDIS ↗

    €814ktheir share
  • IMMUNOSHAPEPartner

    Development of Selective Carbohydrate Immunomodulators Targeting C-type Lectin Receptors on Antigen Presenting Cells

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

  • VIPPartner

    Vaccines and Imaging Partnership

    FP7 (2007 to 2013) · 2014–2018 · Project on CORDIS ↗

    €444ktheir share
  • IMPROVEPartner

    Improving Prostate Cancer Outcome with Vectored Vaccines

    FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗

    €72ktheir share
  • DISCOCoordinator

    A multidisciplinary Doctoral Industrial School on novel preventive strategies against E. Coli infections

    FP7 (2007 to 2013) · 2014–2018 · Project on CORDIS ↗

    €522ktheir share
  • SAMUFLUCoordinator

    Self-amplifying RNA technology applied to the development of a universal influenza vaccine

    FP7 (2007 to 2013) · 2014–2016 · Project on CORDIS ↗

    €187ktheir share
  • SV-STAPH-VAXCoordinator

    Structural Vaccinology to drive the design and optimization of protein antigens for a multicomponent vaccine against Staphylococcus aureus

    FP7 (2007 to 2013) · 2014–2016 · Project on CORDIS ↗

    €187ktheir share
  • RESTAVACCoordinator

    Regulation of Expression of Staphylococcus aureus Vaccine Antigen Candidates

    FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗

    €180ktheir share
  • HOMINPartner

    Host-microbe interactions in health and disease. Interface with the immune system

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €804ktheir share
  • VACTRAINPartner

    Training network for next generation vaccinologists

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €254ktheir share
  • MultiMalVaxPartner

    A Multi-Stage Malaria Vaccine

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €125their share
  • BIOVACSAFECoordinator

    Biomarkers For Enhanced Vaccine Safety

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

  • EMTICSPartner

    European Multicentre Tics in Children Studies

    FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗

    €209ktheir share
  • EUCLIDSPartner

    The genetic basis of meningococcal and other life threatening bacterial infections of childhood

    FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗

    €299ktheir share
  • ADITECPartner

    Advanced Immunization Technologies

    FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗

    €973ktheir share
  • RAPP-IDPartner

    Development of RApid Point-of-Care test Platforms for Infectious Diseases

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

  • TCDIFLUCoordinator

    Impact of adjuvants on T cell differentiation after Influenza Vaccination analyzed at the Single Cell Level

    FP7 (2007 to 2013) · 2011–2013 · Project on CORDIS ↗

    €180ktheir share
  • EIMID ITNCoordinator

    European Initiative for basic research in Microbiology and Infectious Diseases

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €644ktheir share
  • MEGALOVAXCoordinator

    In search of new cytomegalovirus vaccine antigens

    FP7 (2007 to 2013) · 2010–2012 · Project on CORDIS ↗

    €165ktheir share
  • CLOSTNETPartner

    A Clostridal Biology Network to Facilitate European-wide Medical Countermeasures and Commercial Exploitation

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €425ktheir share
  • EIMID-IAPPCoordinator

    European Initiative for basic research in Microbiology and Infectious Diseases - IAPP

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €817ktheir share
  • DEVANICoordinator

    Design of a vaccine to immunize neonates against GBS infections through a durable maternal immune response

    FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗

    €908ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • HIV
  • RNA
  • alkali metals
  • allergology
  • antibiotic resistance
  • antibiotics
  • autoimmune diseases
  • bacteriology
  • bacteriomes
  • biofuels
  • carbohydrates
  • confocal microscopy
  • crystals

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime